Meeting News

Ixekizumab plus background drugs bested background drugs alone in axial SpA

November 21, 2019
ATLANTA — Ixekizumab combined with conventional background medication is superior to both conventional background medication alone and placebo…
Meeting News

Intervention bundle improves flu vaccination rates in RA/JIA patients

November 21, 2019
ATLANTA — An intervention bundle reminding patients with rheumatoid arthritis and juvenile idiopathic arthritis of the benefits of influenza…
Meeting News

Experts create algorithm for management of cutaneous manifestations in lupus

November 20, 2019
Researchers compiled a treatment algorithm for cutaneous manifestations of lupus erythematosus based on data from 104 studies, according to a study…
Meeting News

Upadacitinib improves signs, symptoms in patients with active AS

November 20, 2019
ATLANTA — A daily regimen of 15 mg upadacitinib was significantly more effective than placebo in improving signs, symptoms, function and…
In the Journals

PsA diagnosis often delayed in dermatology vs. rheumatology

November 20, 2019
In the dermatology setting, researchers found a substantial delay from symptom onset to a psoriatic arthritis diagnosis compared with rheumatology…

ACR adds Vectra test to recommended RA activity measures

November 20, 2019
The American College of Rheumatology has added the Vectra blood test, developed by Myriad Genetics, to its list of recommended disease activity…
Meeting News

Mitochondrial abnormalities a prognostic marker for juvenile dermatomyositis

November 20, 2019
ATLANTA — Patients with juvenile dermatomyositis demonstrate obvious mitochondrial abnormalities in the tissue and periphery, supporting the…
Feature

Physicians tapering patients off opioids can turn to HHS guide

November 20, 2019
A recent study suggests that less than a quarter of patients on chronic opioid therapy for noncancer pain are tapered off opioids, and another study…
Meeting News

Common rheumatologic drugs may impede checkpoint inhibitor efficacy

November 20, 2019
ATLANTA — Drugs that have known potential impacts on gut microbiota and are commonly prescribed by rheumatologists can have detrimental impacts…
Meeting News

Maternal use of non-TNF inhibitor biologic, tofacitinib pose minimal infectious risk to offspring

November 19, 2019
ATLANTA — The use of either non-TNF inhibitor biologics or tofacitinib for chronic inflammatory diseases during pregnancy did not significantly…
Meeting News

Tofacitinib bested placebo for disease flares in polyarticular JIA

November 19, 2019
ATLANTA — Results of a double-blind, randomized, placebo-controlled trial showed a clear benefit of tofacitinib in controlling disease flares…
Meeting News

Children with Down syndrome have higher risk for arthritis, delayed diagnosis

November 19, 2019
ATLANTA — Children with Down syndrome are at an increased risk for arthritis at a rate that is two to three times higher than previously…
Cover Story

The Customer is Sometimes Right: Direct-to-consumer Ads in Rheumatology

Healio Rheumatology, November 2019
Direct-to-consumer advertisements in health care occasionally provide patients with helpful information that sends them into the clinic with…
Guest Editorial

Formulary Construction in America: ‘Perfectly Legal’ and ‘Perfectly Wrong’

Healio Rheumatology, November 2019
Madelaine A. Feldman, MD, FACR
How can a system that a) incentivizes higher drug prices; b) steers patients to drugs that make the most money for the middleman; c) creates…
Education Lab

Ace the Case: A 76-Year-Old Female With White Discoloration of Fingers

Healio Rheumatology, November 2019
Learning Objective: Upon successful completion of this educational activity, participants will be better able to assess and treat patients with…
Meeting News

Pain, fatigue topped list of symptoms most important to patients with rheumatic disease

November 19, 2019
ATLANTA — A vast majority of patients with a cross-section of rheumatic diseases reported that pain, fatigue and mental health issues were…
Meeting News

Opioids only modestly improve pain relief, function in OA, not QoL

November 18, 2019
ATLANTA — Among patients with osteoarthritis, opioids demonstrated only moderate benefit for pain and function, while contributing no notable…
FDA News

FDA approves Abrilada, fifth Humira biosimilar

November 18, 2019
The FDA has approved Abrilada, a biosimilar to Humira, making it the fifth biosimilar to the reference drug and 25th biosimilar overall to gain…
Meeting News

Poor health literacy, wait times drive influenza vaccine hesitancy in RA, JIA

November 18, 2019
ATLANTA — Limited knowledge about inactivated vaccines, misconceptions and fears, as well as long wait times and accessibility issues are among…
Meeting News

Gastroenterologist to rheumatologists: Suspect IBD more often

November 18, 2019
ATLANTA — Rheumatologists need to suspect inflammatory bowel disease more often in patients who present with joint pain, particularly in the…